|
| 18/12/2001 |
RETIREMENT OF NON-EXECUTIVE DIRECTOR |
|
| 17/12/2001 |
COLAL-PRED™ COMPLETES DOSING IN PHASE II TRIAL |
|
| 17/12/2001 |
OBESITY DRUG SUCCESSFULLY COMPLETES PHASE I CLINICAL DEVELOPMENT PROGRAMME |
|
| 09/10/2001 |
DIRECTORS SHARE PURCHASES |
|
| 27/09/2001 |
ETHICS COMMITTEE APPROVAL |
|
| 27/09/2001 |
INTERIM REPORT FOR THE SIX MONTHS ENDED 30 JUNE 2001 |
|
| 17/09/2001 |
ALIZYME RECEIVES APPROVAL FOR PHASE IIb CLINICAL TRIAL IN IBS |
|
| 02/05/2001 |
ANNUAL GENERAL MEETING STATEMENT |
|
| 02/04/2001 |
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2000 |
|
| 22/02/2001 |
ADDITIONAL LISTING |
|
| 08/01/2001 |
ALIZYME ANNOUNCES POSITIVE PHASE Ib CLINICAL TRIAL RESULTS WITH OBESITY DRUG ATL-962 |
|
Help